Table 1.
Demographic and clinical features of the 71 patients who survived severe COVID-19 pneumonia [25] and were included in the study and followed up to 12 months after discharge.
| No. | 71 |
|---|---|
| Age (years, range) | 66 [59–73] |
| Sex, F | 26 (37) |
| Smoking history (never/former/current) | 33 (46)/38 (54)/0 (0) |
| Comorbidities | |
| Any | 57 (81) |
| >2 | 19 (27) |
| Arterial hypertension | 42 (59) |
| Cardiovascular disease * | 14 (20) |
| Obesity ** | 20 (28) |
| Diabetes | 12 (17) |
| Dyslipidemia | 24 (34) |
| Chronic renal failure | 1 (1) |
| Neoplasia (active history) | 1 (1) |
| Rheumatic pathology | 5 (7) |
| Immunodepression | 3 (4) |
| Epilepsy | 1 (1) |
| Cirrhosis | 0 (0) |
Data are reported as median [IQR] (continuous/numerical variables) or number (%) (binary/categorical variables). * Including coronary heart disease, cerebrovascular disease, heart failure, and peripheral vascular disease. ** Defined as BMI ≥ 30.